Yariv Houvras

Directeur Technique/Scientifique/R&D chez XILIO THERAPEUTICS, INC.

Consumer Services

Health Technology

Profil

Dr. Yariv J.
Houvras is a Chief Medical Officer at Xilio Therapeutics, Inc. Dr. Houvras was previously employed as a SVP-Clinical & Translational Development by Tubulis GmbH.
He received his undergraduate degree from the University of Michigan and a doctorate degree from Icahn School of Medicine at Mount Sinai.

Postes actifs de Yariv Houvras

Sociétés	Poste	Début
XILIO THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	28/09/2026

Tous les postes actifs de Yariv Houvras

Anciens postes connus de Yariv Houvras

Sociétés	Poste	Fin
Tubulis GmbH Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors	Corporate Officer/Principal	-

Voir l'expérience en détail de Yariv Houvras

Formation de Yariv Houvras

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Yariv Houvras

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xilio Therapeutics, Inc. Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies	Health Technology
Tubulis GmbH Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors	Health Technology